분만의료기관의 국가 B형감염 수직감염 예방사업활동 실태 = Status of National Antenatal Hepatitis B Screening and Neonatal Immunization Program in Korea

다국어 초록 (Multilingual Abstract)

Objectives : The purpose of this study was to survey current status of national antenatal
hepatitis B screenings and neonatal immunization programs among clinics and hospitals in
Korea.
Methods : From July 2002 to December 2002, 848 hospitals(507,151 deliveries) were
surveyed and 341 hospitals(279,734 deliveries, 40.2%) completed the survey.
Results : 298(87.4%) hospitals were participating in the national program for preventing
vertical transmission of hepatitis B. 93.6% of respondents agreed in the necessity of the
screening. 76.9% had seen brochures about the screening program and 67.5% of hospital had
educated their staff about the program.
Many respondents(23.2%) felt too complex about the reimbursement process and Some
respondents(19.1%) answered complicatedness filling the documents. Average of 2.8 and 1.6 persons were involved in the program at hospitals and clinics respectively. Many respondents(8.2%)
found lack of public information was urgent problem in the national screening program.
Conclusions : It is important to have more hospitals and clinics participating in the screening program by active public information and exchanging informations among the various related groups.

참고문헌 (Reference)

1 "Viral Hepatitis in Pregnancy" July1998

2 "Need for immunoprophylaxisin infants born to HBsAg positive carriermothers who are HBs Ag negative" jpediatric1984

3 "Integration of hepatitis Bvirus DNA into the genome of liver cellsin chronic liver disease and hepatocellular carcinoma studies in percutaneous liverbiopsies and post mortum tissue" 1067-1073, jmed1981

4 "Hepatitis B vaccination in high-riskinfants:10-year follow-up" 179 : 1319-1325, 1999

5 "Hepatitis B surface antigen in the serum ofinfants after delivery from asymptomaticcarrier mothers" 87 : 360-363, 1975

6 "Hepatitis B immuneglobulin(HBIG)efficacy in theinterruption of perinatal transmission ofhepatitis B virus carrier state initial reportof randomized double-blind placebocontrolled trial" 318 : 388-393, 1981